ASM Clermont Auvergne

Valbiotis Publishes Its 2022 Annual Results and Provides an Update on Its Strategic Roadmap

Retrieved on: 
수요일, 3월 15, 2023
Science, Biotechnology, Research, Pharmaceutical, Health, Medical Devices, Fitness & Nutrition, Clinical Trials, United Nations Global Compact, Statutory auditor, Corporate social responsibility, ISO, PEA, Risk, AASLD, Partnership, Prediabetes, Research and development, Liver, Dyslipidemia, LDL, Université Laval, NASH, NAFL, Hypercholesterolemia, Phase, Patient, Type 2 diabetes, ASM Clermont Auvergne, De novo, Hepatology, INAF, CHF, INSIGHT, American Association of Clinical Endocrinologists, Development, Marketing, CSR, Volunteering, ANR, University, Food court, R, Pharmaceutical industry, Cryptocurrency

Sébastien PELTIER, Chairman of the Board of Directors at Valbiotis, comments: "During the year 2022, Valbiotis continued to pursue its R&D roadmap while providing itself with the means to accelerate its commercial strategy.

Key Points: 
  • Sébastien PELTIER, Chairman of the Board of Directors at Valbiotis, comments: "During the year 2022, Valbiotis continued to pursue its R&D roadmap while providing itself with the means to accelerate its commercial strategy.
  • The year 2022 was marked by the positive results of the Phase II HEART study, announced in June ( press release of June 13, 2022 ).
  • Regarding TOTUM•854, Valbiotis launched the Phase II/III INSIGHT and INSIGHT 2 clinical studies in early 2022 ( press release of February 17, 2022 ).
  • At the beginning of 2022, Valbiotis updated the development strategy for TOTUM•448 ( press release of January 6, 2022 ).

 Alpha Blue Ocean Reaffirms its Commitment to the French Group Europlasma, the Auvergne-Rhône-Alpes Region and the Ministry of Economy for the Re-industrialization of the Forges de Gerzat

Retrieved on: 
목요일, 1월 20, 2022
Professional Services, Finance, Ministry, Technology, State, Ticker, ASM Clermont Auvergne, Ministry of the Economy and Finance (France), Documentation, Innovation, Regional Council, Forges, CEO, Professional, Interview, Acquisition, Time, Health, Economy, Laurent Wauquiez, CIO, Regional Council of Auvergne-Rhône-Alpes, Renewable energy, Security (finance), Management, Industry

The project has been financed with the support of Alpha Blue Ocean, which has committed up to 25 million euros over the next seven years.

Key Points: 
  • The project has been financed with the support of Alpha Blue Ocean, which has committed up to 25 million euros over the next seven years.
  • This funding is based on pure long-term debt (subject to certain previous conditions, the definitive documentation is still under negotiation).
  • This is in addition to the currently active convertible bond facility of 100 million euros executed in 2021 between Alpha Blue Ocean and Europlasma.
  • Pierre Vannineuse, Founder and CIO of Alpha Blue Ocean: "We have always believed in the possibilities offered by Europlasma's innovative and relatively unique technology.